Comparing the effectiveness and costs of Bevacizumab to Ranibizumab in patients with Diabetic Macular Edema: a randomized clinical trial (the BRDME study)

Schauwvlieghe, A.M.E.; Dijkman, G.; Hooymans, J.M.; Verbraak, F.D.; Hoyng, C.B.; Dijkgraaf, M.G.W.; ... ; Schlingemann, R.O. (2015)

Article / Letter to editor

• Diabetic retinopathy
• Diabetic macular edema
• VEGF
• Ranibizumab
• Lucentis
• Bevacizumab
• Avastin
• Randomized clinical trial

• All authors: Schauwvlieghe, A.M.E.; Dijkman, G.; Hooymans, J.M.; Verbraak, F.D.; Hoyng, C.B.; Dijkgraaf, M.G.W.; Leeuwen, R. van; Vingerling, J.R.; Moll, A.C.; Schlingemann, R.O.
• Date: 2015-07-07
• Journal: BMC Ophthalmology
• Volume: 15
• DOI: doi:10.1186/s12886-015-0043-x